Herlev
Denmark
60
2026-05-07
20
2026-02-24
These are the the leading inventors for applications assigned to NORDIC BIOSCIENCE A/S:
NORDIC BIOSCIENCE A/S based in Herlev, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Assay for Assessing Cancer
#2 | 2026-01-29Type XIX Collagen Assay
#3 | 2025-04-17LG3 Assay
#4 | 2025-03-06Anastellin Biomarker
#5 | 2025-03-06Anastellin Biomarker
#6 | 2025-01-16Method for Detecting Cancer in a Patient
#7 | 2025-01-09COLLAGEN TYPE VII ALPHA 1 ASSAY
#8 | 2024-11-21Collagen Type XX Assay
#9 | 2024-06-27Type XIX Collagen Assay
#10 | 2024-04-18Immunoassay for Detecting Eosinophilic Esophagitis
#11 | 2024-03-14Assay for Detecting Collagen XI Biomarkers
#12 | 2024-01-11Elastin Assay
#13 | 2024-01-04Biomarker of Fibrosis
#14 | 2023-11-09Assay for Assessing Cancer
#15 | 2023-10-26Collagen Type XVIII Assay
#16 | 2023-09-07Collagen Type XVI Assay
#17 | 2023-08-17Assay for Assessing Heart Failure
#18 | 2023-06-15Calprotectin Assay
#19 | 2023-05-18 ✅ Patent 12,560,610 granted on 2026-02-24SPARC Assay
#20 | 2023-02-16Tumstatin Assay
#21 | 2023-02-02 ✅ Patent 12,559,543 granted on 2026-02-24Neo-Epitope Specific Assay Measuring Protease Mediated Degradation of Type IV Collagen
#22 | 2022-10-06Assay for Assessing Heart Failure
#23 | 2022-07-21 ✅ Patent 12,391,747 granted on 2025-08-19Type XXIII Collagen Assay
#24 | 2022-06-23Immunoassay for Collagen Type VIII Sequences
#25 | 2022-05-12 ✅ Patent 12,366,582 granted on 2025-07-22Collagen Type X Alpha-1 Assay
#26 | 2021-09-23COLLAGEN TYPE VII ALPHA 1 ASSAY
#27 | 2021-03-18SPARC Assay
#28 | 2020-12-03Elastin Assay
#29 | 2020-10-29Tumstatin Assay
#30 | 2020-06-04Collagen Type X Alpha-1 Assay
#31 | 2020-05-21 ✅ Patent 11,531,028 granted on 2022-12-20Collagen type X alpha-1 assay
#32 | 2020-04-23Lysyl Oxidase-Like 2 Assay
#33 | 2020-03-19Collagen Type XVIII Assay
#34 | 2019-10-10 ✅ Patent 11,634,479 granted on 2023-04-25Immunoassay for collagen type VI
#35 | 2019-08-22Nidogen-1 Fragments Assay
#36 | 2019-06-27COLLAGEN TYPE VII ALPHA 1 ASSAY
#37 | 2018-09-20Biochemical Markers for Pulmonary and Other Diseases
#38 | 2018-08-23Immunoassay for Collagen Type VIII Sequences
#39 | 2018-03-29Immunoassay for Collagen Type VI Sequence
#40 | 2017-06-22 ✅ Patent 9,880,177 granted on 2018-01-30Fibrosis biomarker assay
#41 | 2016-11-17 ✅ Patent 10,001,490 granted on 2018-06-19Biochemical markers for pulmonary and other diseases
#42 | 2016-09-29 ✅ Patent 10,267,809 granted on 2019-04-23Biochemical markers for CVD risk assessment
#43 | 2016-09-01Biomarkers of Alzheimer's Disease Progression
#44 | 2016-08-04 ✅ Patent 9,835,631 granted on 2017-12-05Combined biomarker measurement of fibrosis
#45 | 2016-05-05Collagen Type X Alpha-1 Assay
#46 | 2016-03-31 ✅ Patent 9,606,130 granted on 2017-03-28Fibrosis biomarker assay
#47 | 2016-03-17Collagen Type VI Alpha-1 Assay
#48 | 2016-03-03 ✅ Patent 9,726,674 granted on 2017-08-08PIIINP neo-epitope assay
#49 | 2015-05-07 ✅ Patent 9,459,260 granted on 2016-10-04Detection of diagnostic peptides
#50 | 2014-10-02 ✅ Patent 9,500,659 granted on 2016-11-22In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein
#51 | 2013-10-03ASSAY FOR A TYPE II COLLAGEN BIOMARKER
#52 | 2013-03-28TREATMENT OF CARTILAGE RESORPTION
#53 | 2012-02-23TREATMENT OF DIABETES AND METABOLIC SYNDROME
#54 | 2012-02-23 ✅ Patent 9,404,932 granted on 2016-08-02Pathology biomarker assay
#55 | 2010-12-23 ✅ Patent 9,359,633 granted on 2016-06-07Biochemical markers for CVD risk assessment
#56 | 2010-12-16BIOCHEMICAL MARKERS FOR CVD RISK ASSESSMENT
#57 | 2010-08-19 ✅ Patent 9,206,464 granted on 2015-12-08Fibrosis biomarker assay
#58 | 2009-08-27 ✅ Patent 7,844,090 granted on 2010-11-30Method of deriving a quantitative measure of a degree of calcification of an aorta
#59 | 2009-07-30 ✅ Patent 8,280,126 granted on 2012-10-02Cartilage curvature
#60 | 2008-09-18 ✅ Patent 8,835,389 granted on 2014-09-16Use of calcitonin for the treatment of RA
Also check out Nordic Bioscience A/S's (Herlev, Denmark) applicant profile with 18 patent applications submitted.
16101 ⎘